Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.
Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease. Int J Impot Res. 2019 Jan; 31(1):15-19.